Fairvalue-Calculator Fairvalue-Calculator
EN DE

Value Added Technology Co (043150) Fair Value & Analysis

Healthcare · KR · Market cap 287B KRW

Price17,800 KRW
Fair Value60,242 KRW
Upside+238.4%
Quality95/100
Evidence: High Range 45,181 KRW – 75,302 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Value Added Technology Co (043150) currently trades at 17,800 KRW, while our model-based Fair Value estimate is 60,242 KRW — implying the stock looks roughly 238.4% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Value Added Technology Co., Ltd. develops, manufactures, and sells dental medical X-ray devices in Korea. It offers 2D, 3D, and intra oral imaging products. The company was founded in 1992 and is headquartered in Hwaseong, South Korea.

Open the full interactive analysis →

Similar stocks

InBody Co (041830) +10% i-SENS, Inc (099190) -84% Mediana Co (041920) +13% Meta Biomed Co (059210) +147% Sewoon Medical Co (100700) +186% Medicon Hellas S.A (MEDIC) +5%

Frequently asked questions

Is Value Added Technology Co (043150) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 60,242 KRW versus a price of 17,800 KRW — about +238% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 043150?
Our 21-model fair value for Value Added Technology Co is 60,242 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 17,800 KRW.
What is the quality score of 043150?
Value Added Technology Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.